- Home
- PODD vs HOLX Comparison
PODD vs HOLX Comparison
Compare PODD & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PODD
- HOLX
- Stock Information
- Founded
- PODD 2000
- HOLX 1985
- Country
- PODD United States
- HOLX United States
- Employees
- PODD N/A
- HOLX N/A
- Industry
- PODD Medical/Dental Instruments
- HOLX Medical Electronics
- Sector
- PODD Health Care
- HOLX Health Care
- Exchange
- PODD Nasdaq
- HOLX Nasdaq
- Market Cap
- PODD 17.2B
- HOLX 16.3B
- IPO Year
- PODD 2007
- HOLX 1990
- Fundamental
- Price
- PODD $246.80
- HOLX $57.56
- Analyst Decision
- PODD Buy
- HOLX Buy
- Analyst Count
- PODD 17
- HOLX 14
- Target Price
- PODD $294.65
- HOLX $84.17
- AVG Volume (30 Days)
- PODD 878.5K
- HOLX 3.7M
- Earning Date
- PODD 05-08-2025
- HOLX 05-01-2025
- Dividend Yield
- PODD N/A
- HOLX N/A
- EPS Growth
- PODD 96.55
- HOLX 50.83
- EPS
- PODD 5.78
- HOLX 3.16
- Revenue
- PODD $2,071,600,000.00
- HOLX $4,039,000,000.00
- Revenue This Year
- PODD $20.53
- HOLX $3.37
- Revenue Next Year
- PODD $17.42
- HOLX $5.40
- P/E Ratio
- PODD $42.67
- HOLX $18.24
- Revenue Growth
- PODD 22.07
- HOLX 1.76
- 52 Week Low
- PODD $160.19
- HOLX $56.27
- 52 Week High
- PODD $289.46
- HOLX $84.67
- Technical
- Relative Strength Index (RSI)
- PODD 42.59
- HOLX 39.33
- Support Level
- PODD $241.54
- HOLX $56.27
- Resistance Level
- PODD $258.00
- HOLX $59.02
- Average True Range (ATR)
- PODD 13.13
- HOLX 2.18
- MACD
- PODD -0.61
- HOLX -0.19
- Stochastic Oscillator
- PODD 34.84
- HOLX 23.49
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.